Therapeutic role of EGFR - Tyrosine kinase inhibitors in non-small cell lung cancer with leptomeningeal metastasis

Leptomeningeal metastasis (LM) is a significant complication that advances fast and has a poor prognosis for patients with advanced non-small cell lung cancer (NSCLC) who have epidermal growth factor receptor (EGFR) mutations. Current therapies for LM are inconsistent and ineffective, and establishe...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Caiyan Jia, Qian Xu, Lu Zhao, Fanming Kong, Yingjie Jia
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Elsevier 2024-01-01
Reeks:	Translational Oncology
Onderwerpen:	Leptomeningeal metastasis Epidermal growth factor receptor EGFR tyrosine kinase inhibitors Non-small cell lung cancer Osimertinib
Online toegang:	http://www.sciencedirect.com/science/article/pii/S1936523323002188
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!